NCT05274620

Brief Summary

The purpose of this study is to evaluate the implementation of IntelliCare as a frontline intervention within health care settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
82

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started May 2022

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

March 10, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2024

Completed
Last Updated

July 31, 2024

Status Verified

July 1, 2024

Enrollment Period

2 years

First QC Date

March 2, 2022

Last Update Submit

July 30, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Reach

    1\. Number of eligible patients during trial period; 2) number offered IntelliCare; 3) number initiating IntelliCare; 4) number completing IntelliCare

    5 months

  • Cost

    Cost of delivering IntelliCare per patient

    7 months

Secondary Outcomes (1)

  • Depression

    Administered weekly over 8 weeks

Study Arms (1)

IntelliCare

OTHER

8 weeks of IntelliCare

Behavioral: IntelliCare

Interventions

IntelliCareBEHAVIORAL

A mobile intervention that use principles of computerized therapy to decrease symptoms of depression

IntelliCare

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient who have been identified as depressed or anxious by a care provider in one of the participating healthcare organizations.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Northwestern Medicine Dept of Psychiatry

Chicago, Illinois, 60611, United States

Location

MacLeod HealthCare

Florence, South Carolina, 29506, United States

Location

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Carolyn MacIver

    Adaptive Health, Inc

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 2, 2022

First Posted

March 10, 2022

Study Start

May 1, 2022

Primary Completion

April 30, 2024

Study Completion

April 30, 2024

Last Updated

July 31, 2024

Record last verified: 2024-07

Data Sharing

IPD Sharing
Will not share

Locations